Cargando…
Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers
OBJECTIVE: We aimed to evaluate the potential of serum neurofilament light chain (sNfL) and serum brain-derived neurotrophic factor (sBDNF) as reliable biomarkers for paclitaxel-induced peripheral neuropathy (PIPN). METHODS: Forty-eight patients with gynecologic cancer scheduled to undergo six cycle...
Autores principales: | Kim, Su-Hyun, Kim, Ki Hoon, Hyun, Jae-Won, Kim, Ji Hyun, Seo, Sang-Soo, Kim, Ho Jin, Park, Sang-Yoon, Lim, Myong Cheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428708/ https://www.ncbi.nlm.nih.gov/pubmed/36059704 http://dx.doi.org/10.3389/fonc.2022.942960 |
Ejemplares similares
-
Corrigendum: Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers
por: Kim, Su-Hyun, et al.
Publicado: (2023) -
Serum neurofilament light chain levels as a biomarker of neuroaxonal injury and severity of oxaliplatin-induced peripheral neuropathy
por: Kim, Su-Hyun, et al.
Publicado: (2020) -
Plasma neurofilament light chain concentration in the inherited peripheral neuropathies
por: Sandelius, Åsa, et al.
Publicado: (2018) -
Development of the short version of the Gynecologic Cancer Lymphedema Questionnaire: GCLQ-7
por: Kim, Se Ik, et al.
Publicado: (2017) -
Neurofilament light as a predictive biomarker of unresolved chemotherapy-induced peripheral neuropathy in subjects receiving paclitaxel and carboplatin
por: Burgess, B. L., et al.
Publicado: (2022)